For example, the study by Tong et al. [59] indicated that inhibiting intracellular NGAL expression with siRNA in A549 lung cancer cells increases cell death, whereas cell treatment with rhNGAL, even at high doses, had no effect on cell viability. This evidence concerns the gene LCN2 and lung carcinoma.